Bayer appoints new Head of Global Innovation & Development of Consumer Health
Bayer Healthcare has recently appointed its new Head of Global Innovation & Development of Consumer Health. Dr Sharon James will succeed Dr John O’Mullane, who is set to retire at the end of December.
Appointed as Director for Neurosciences and GI back in the 1990s, Dr James undertook a number of roles at Reckitt Benckiser, ultimately becoming Senior Vice President for PepsiCo in 2011. She has extensive expertise in leading global teams, spearheading a number of product developments, re-joining Reckitt Benckiser in 2011.
In this new role, Dr James will take the business in a new direction in the development of new health products and services within a growing digital age.
- Taiba Hospital: Patient care with promise
- New pilot program could overhaul traditional health FDA practices
- Google’s News Lab unveils new healthcare focused tool
"With more than 25 years' experience in the fast-moving consumer goods and consumer product sector, Sharon has a proven record of developing and supporting products for leading consumer brands," said Erica Mann, Member of the Board of Management, Bayer AG, and President, Consumer Health Division, Bayer.
"I know that under Sharon’s leadership, Bayer will continue to successfully develop and deliver new innovative self-care solutions that help people around the world be a little healthier every day."
Known for embedding a 'consumer-first' mindset in R&D, Dr James is also a strong advocate of open innovation – collaborating extensively with a broad range of partners across the health industry.
Dr. James holds a PhD in Neurobiology from University College London, Department of Anatomy and Developmental Biology and a Bachelor of Science degree in Medical Biochemistry from University of London.
Zoom enters the healthcare market - a timeline
Since the pandemic began Zoom has become an integral part of daily life for people working from home, as well as a vital tool for families and friends to communicate. However it's also been eyeing up the healthcare space since 2017, and following the boom in telehealth the company has been rolling out additional services. Here we chart Zoom's move into healthcare.
2011 - 2013
Zoom is founded in San Jose, California, by Eric Yuan, formerly of Cisco. He got the idea to create a video calling platform from his visits to his girlfriend while he was a student, which would take 10 hours by train.
A beta version is released in 2012, which can host up to 15 participants. In 2013 this rises to 25. By mid-2013, Zoom has 1 million users.
2014 - 2017
Zoom attracts investors, including Sequoia Capital, Emergence and Horizon Ventures. By January 2017, Zoom has a series D funding worth $100 million.
2017 - 2019
Zoom for Telehealth launches, including an integration with EHR system Epic. It has cloud-based video, audio, and content sharing features, a "waiting room" for patients, and can easily be integrated into healthcare provider's workflows.
In 2019 Zoom goes public, with its IPO rising 72% in one day.
As a result of the pandemic, Zoom gains 2.2 million new users, more than in the whole of 2019. On the 23rd of March alone - the day the UK lockdown was announced - the platform was downloaded 2.13 million times around the world.
Share prices rise to around $150, and founder and chief executive Eric Yuan becomes one of the world's richest people, with an estimated net worth of $7.9 billion.
Early security issues are addressed by encrypting data with the Advanced Encryption Standard (AES). By now the the platform allows 99 people to be on a call simultaneously
New features launch, including Zoom Home and Zoom for Chats. Throughout the year the platform is used to replace most kinds of real life events: work meetings, online classrooms, church services and social events.
Renamed Zoom for Healthcare, users can share secured video, audio, and content through desktops, mobile phones, and conference devices. As well as Epic, it can be integrated with Strmr, IntakeQ, and Practice Better.
It can also be used with diagnostic cameras and other point-of-care devices, including digital stethoscopes.
In an interview with Korea Biomedical Review, Zoom Global Healthcare Lead Ron Emerson said: "Our service is not simply a virtual care and telemedicine platform but a multi-purpose platform that can satisfy the needs of healthcare institutions."
"It can be used for administrative tasks, including telemedicine, medical team meetings, recruitment, medical education, employee training, and disease prevention. Analysing electronic records managed by Zoom could provide meaningful insights into patient care."
Phoenix Children's Hospital, Belfast's Hospital Services Limited, Butler Health Services and the global Project ECHO are among Zoom for Healthcare's current customers.